Correlation Between Cabio Biotech and Eyebright Medical

Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Eyebright Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Eyebright Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cabio Biotech Wuhan and Eyebright Medical Technology, you can compare the effects of market volatilities on Cabio Biotech and Eyebright Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Eyebright Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Eyebright Medical.

Diversification Opportunities for Cabio Biotech and Eyebright Medical

0.29

Correlation Coefficient

Cabio Biotech  Eyebright Medical

Modest diversification

The 3 months correlation between Cabio and Eyebright is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Eyebright Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyebright Medical and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Eyebright Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyebright Medical has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Eyebright Medical go up and down completely randomly.

Pair Corralation between Cabio Biotech and Eyebright Medical

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to generate 0.97 times more return on investment than Eyebright Medical. However, Cabio Biotech Wuhan is 1.03 times less risky than Eyebright Medical. It trades about -0.03 of its potential returns per unit of risk. Eyebright Medical Technology is currently generating about -0.03 per unit of risk. If you would invest  3,575  in Cabio Biotech Wuhan on October 11, 2024 and sell it today you would lose (1,766) from holding Cabio Biotech Wuhan or give up 49.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cabio Biotech Wuhan  vs.  Eyebright Medical Technology

Cabio Biotech Wuhan

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eyebright Medical

Risk-Adjusted Performance

3 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eyebright Medical Technology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Eyebright Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Cabio Biotech and Eyebright Medical

The main advantage of trading using opposite Cabio Biotech and Eyebright Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Eyebright Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyebright Medical will offset losses from the drop in Eyebright Medical's long position.

The idea behind Cabio Biotech Wuhan and Eyebright Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.